drugset / Trial / NCT02584738

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

NCT02584738

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate the effectiveness of nebulized magnesium sulfate in patient with moderate to severe asthma exacerbation in pediatric emergency

Timeline

Start
2015-09
Primary completion
2016-01
Completion
2018-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 150 mg Inhaled
Background Ipratropium Small molecule 250 ug Inhaled
Background Methylprednisolone Other / unclassified 2 mg/kg Intravenous
Background Prednisolone Other / unclassified 2 mg/kg Oral
Background Salbutamol Unknown 2.5 mg Inhaled
Background Salbutamol Unknown 5 mg Inhaled

Indications